What we do
The group Multi-omics for healthcare materials focuses on deconvolution of disease-associated cellular signaling networks in order to inform precise imunoengineering solutions. Activities of the group are centered on generating and analyzing biomedical multi-omics datasets that can assist development of new materials for personalized healthcare applications, primarily in cancer. This involves development of new software tools, employment of advanced data analytics and modeling of material properties. Together with clinical and industrial partners, we seek to implement these new concepts into next generation healthcare solutions.
Find out more about the Group’s activities
